EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial

Andrew Seaman iD, Ryan Cook, Gillian Leichtling, Megan C Herink, Tonhi Gailey, Joanna Cooper, Hunter C Spencer, Jane Babiarz, Christopher Fox, Ann Thomas, Judith M Leahy, Jessica E Larsen und 1 weitere

Clinical Infectious Diseases · 2025

DOI: 10.1093/cid/ciae520 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Andrew Seaman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Section of Addiction Medicine, Division of General Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University. Hauptthemen laut MEDLINE: Telemedicine, Hepatitis C, Peer Group, Substance Abuse, Intravenous. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIH HHS, National Institute on Drug Abuse of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis C virus (HCV) elimination requires treating people who use drugs (PWUD), yet <10% of PWUD in the United States access HCV treatment; access is especially limited in rural communities.

Methods

We randomized PWUD with HCV viremia and past 90-day injection drug or nonprescribed opioid use in 7 rural Oregon counties to peer-assisted telemedicine HCV treatment (TeleHCV) versus peer-assisted referral to local providers (enhanced usual care [EUC]). Peers supported screening and pretreatment laboratory evaluation for all participants and facilitated telemedicine visits, medication delivery, and adherence for TeleHCV participants. Generalized linear models estimated group differences in HCV viral clearance (primary outcome) and HCV treatment initiation and completion (secondary outcomes).

Results

Of the 203 randomized participants (100 TeleHCV, 103 EUC), most were male (62%), White (88%), with recent houselessness (70%), and used methamphetamines (88%) or fentanyl/heroin (58%) in the past 30 days. Eighty-five of 100 TeleHCV participants (85%) initiated treatment versus 13 of 103 (12%) EUC participants (relative risk [RR], 6.7 [95% confidence interval {CI}, 4.0–11.3]; P < .001). Sixty-three of 100 (63%) TeleHCV participants versus 16 of 103 (16%) EUC participants achieved viral clearance 12 weeks after anticipated treatment completion date (RR, 4.1 [95% CI: 2.5–6.5]; P < .001).

Conclusions

The Peer TeleHCV treatment model substantially increased HCV treatment initiation and viral clearance compared to EUC. Replication in other rural and low-resource settings could further World Health Organization HCV elimination goals by expanding and decentralizing treatment access for PWUD. Clinical Trials Registration. NCT04798521.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelemedicineHepatitis CPeer GroupSubstance Abuse, IntravenousDrug UsersHumansMaleFemaleAdultMiddle AgedOregonAntiviral AgentsRural PopulationHepacivirus

Stichwörter der Autor:innen

hepatitis C virusinjection drug usepeer supportruraltelemedicine

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Section of Addiction Medicine, Division of General Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University.
  • Comagine Health.
  • College of Pharmacy, Oregon State University.
  • Division of General Internal Medicine and Geriatrics, Department of Medicine, Oregon Health & Science University.
  • Oregon Health Authority.
  • Health Systems Division, Behavioral Health Services, Oregon Health Authority, Portland.

ORCID-Profile: Andrew Seaman, P Todd Korthuis

Förderung

  • NIDA NIH HHS
  • NIH HHS
  • National Institute on Drug Abuse of the National Institutes of Health
  • National Institutes of Health

Zitieren

APA

Seaman, A., Cook, R., Leichtling, G., Herink, M. C., Gailey, T., Cooper, J., Spencer, H. C., Babiarz, J., Fox, C., Thomas, A., Leahy, J. M., Larsen, J. E., & Korthuis, P. T. (2025). Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae520

Vancouver

Seaman A, Cook R, Leichtling G, Herink MC, Gailey T, Cooper J, et al. Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciae520

BibTeX
@article{Seaman2025,
  author = {Seaman, Andrew and Cook, Ryan and Leichtling, Gillian and Herink, Megan C and Gailey, Tonhi and Cooper, Joanna and Spencer, Hunter C and Babiarz, Jane and Fox, Christopher and Thomas, Ann and Leahy, Judith M and Larsen, Jessica E and Korthuis, P Todd},
  title = {Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  doi = {10.1093/cid/ciae520}
}
Kostenlos starten →